Telo Genomics Announces $250,000 Term Loan Facility
Vancouver, British Columbia--(Newsfile Corp. - November 6, 2026) - Telo Genomics Corp. (TSXV: TELO) (OTCQB: TDSGF) (the "Company" or "Telo Genomics"), a leader in the development of diagnostic and prognostic tests based on three-dimensional analysis of telomeres (which are the ends of chromosomes), today announced that it closed a term loan agreement effective October 29, 2026, with BrightArc Capital Adminco 1 Inc. (the "Lender") for a principal amount of $250,000 (the "Term Loan").The Term Loan...
Forfait Gratuit · Plus 29 $ CA ou Pro 99 $ CA/mois


